期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

个体化医疗中分子诊断适宜技术 被引量：7

Appropriate technologies for molecular diagnostic in personalized medicine
原文传递
导出
摘要 随着基因组学、生物信息学、T程学、计算机学等多学科的交叉和融合，分子诊断技术得到迅猛发展。越来越多的分子诊断技术应用于疾病的预防、诊断、治疗和预后判断，这为检验医学的发展提供巨大的机遇和挑战。不同的分子诊断技术有其相应的临床使用范围，如何选择适宜的分子诊断技术用于个体化医疗是当前检验科面临的关键问题。r中华检验医学杂志，2014，37：324-326） With the development of genomics, bioinformatlon, engmeenng, computer SClellt：t~ illltl other fields, it has witnessed explosive growth of molecular diagnostic technologies. More and more technologies are used in desease diagnosis, therapy and prevention, which have presented a huge opportunity and challenge for clinical laboratory. Each technology has corresponding field of application, so it is a crucial problem for clinical laboratory to select appropriate molecular diagnostic technology for personalized medicine. （Chin J Lab Med ,2014 ,37 ： 32 4-326 ）
作者 李艳
机构地区 武汉大学人民医院医学检验中心
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2014年第5期324-326,共3页 Chinese Journal of Laboratory Medicine
关键词 个体化医学 分子诊断技术 核酸扩增技术 序列分析 DNA 核酸杂交 Individualized medicine Molecular diagnostic techniques Nucleic acidamplification techniques Sequence analysis, DNA Nucleic acid hybridization
分类号 R450 [医药卫生—治疗学]
  • 相关文献

参考文献9

  • 1国家发展和改革委员会,卫生部,国家中医药管理局.关于规范医疗服务价格管理及有关问题的通知.201245^04.
  • 2Schuster SC. Next-generation sequencing transforms today's biology[J]. Nat Methods, 2008 , 5: 16 -18.
  • 3Mardis ER. The impact of next-generation sequencing technology on genetics[J]. Trends Genet, 2008,24: 133-141.
  • 4孙长贵,成军.分子诊断技术在临床微生物学检验中的应用[J].中华检验医学杂志,2013,36(2):109-112. 被引量：16
  • 5王建飞,石远凯,韩晓红.肿瘤分子靶点检测的方法学[J].中华检验医学杂志,2012,35(5):478-480. 被引量：2
  • 6Soon WW, Hariharan M, Snyder MP. High-throughput sequencing for biology and medicine[J]. Mol Syst Biol, 2013 , 9: 640.
  • 7Miller MB,Tang YW. Basic concepts of microarrays and potential applications in clinical microbiology[J]. Clin Microbiol Rev,2009,22 : 6J1 -633.
  • 8韩晓红,马丽,石远凯.肿瘤个体化治疗的现状和前景[J].中华检验医学杂志,2011,34(4):293-299. 被引量：13
  • 9Kimura H, Suminoe M, Kasahara K, et al. Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of responseto gefitinib[J]. Br J Cancer,2007 , 97 : 778-784.

二级参考文献36

  • 1Whitehall V, Tran K, Umapathy A, et al. A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting. J Mol Diagn, 2009,11:543-552.
  • 2Franklin WA, Haney J, Sugita M, et al. KRAS mutation : comparison of testing methods and tissue sampling techniques in colon cancer. J Mol Diagn, 2010,12:43-50.
  • 3Han HS, Lim SN, An JY, et al. Detection of EGFR mutation status in lung adenocarcinoma specimens with different proportions of tumor cells using two methods of differentia[ sensitivity. J Thorac Oncol, 2012,7:355-364.
  • 4Song C, Milbury CA, Li J, et al. Rapid and sensitive detection of KRAS mutation after fast-COLD-PCR enrichment and high- resolution melting analysis. Diagn Mol Pathol, 2011,20:81-89.
  • 5Farifia Sarasqueta A, Moerland E, de Bruyne H, et al. SNaPshot and StripAssay as valuable alternatives to direct sequencing for KRAS mutation detection in colon cancer routine diagnostics. J Mol Diagn, 2011,13:199-205.
  • 6Kimura H, Fujiwara Y, Sone T, et al. High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients. Cancer Sci, 2006,97:642- 648.
  • 7Rosell R, Moran T, Queralt C, et al. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med, 2009,361:958-967.
  • 8Fassina A, Gazziero A, Zardo D, et al. Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis. J Clin Pathol, 2009,62:1096-1102.
  • 9Zhou Q, Zhang XC, Chen ZH, et al. Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer. J Clin Oncol, 2011,29: 3316-3321.
  • 10Dowsett M, Bartlett J, Ellis IO, et al. Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. J Pathol, 2003,199:418-423.

共引文献28

同被引文献67

  • 1赵晓航,钱阳明.生物样本库——个体化医学的基础[J].转化医学杂志,2014,3(2):69-73. 被引量：23
  • 2刘瑛,陈学光,陈海斌.医学独立实验室的发展及营销策略[J].中华医院管理杂志,2005,21(11):777-778. 被引量：18
  • 3Southern EM. Detection of specific sequences among DNA frag- ments separated by gel electrophoresis. 1975 [J]. Biotechnology, 1992, 24: 122-139.
  • 4Rudkin GT, Stollar B. High resolution detection of DNA-RNA hy- brids in situ by indirect immuno fluorescence [J]. Nautre, 1977, 265 (5593):472-273.
  • 5Miller MB, Tang YW. Basic concepts of microarrays and potential applications in clinical microbiology [J]. Clin Microbiol Rev, 2009, 22(4):611-633.
  • 6Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-ter- minating inhibitors [J]. Proc Natl Acad Sci USA, 1997, 74 (12): 5463-5467.
  • 7Ronaghi M, Karamohamed S, Pettemson B, et al. Real-time DNA sequencing using detection of pyrophosphate re lease [J]. Anal Bioehem, 1996, 242(1):84-89.
  • 8Ronaghi M, Uheln M, Nyren P. A sequencing method based on real-time pyrophosphate[J]. Science, 1998, 281(5375):363.
  • 9Soon WW, Hariharm M, Snyder MP. High-through put sequencing for biology and medicine[J]. Mol Syst Biol, 2013,9,640.
  • 10Wapner R J, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis [J]. N Engl J Med, 2012, 367(23):2175-2184.

引证文献7

二级引证文献36

中华检验医学杂志
2014年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部